Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (firstname.lastname@example.org).
To the Editor: In a report by Dr Andersson and colleagues,1 clopidogrel treatment after MI was not associated with the same benefits for persons with diabetes as for those without diabetes. Clopidogrel was associated with a lower reduction in all-cause mortality and cardiovascular mortality among those with diabetes compared with those without diabetes, even after controlling for multiple important medical conditions.
Ziegelstein RC. Treatment With Clopidogrel After Myocardial Infarction. JAMA. 2012;308(23):2456-2457. doi:10.1001/jama.2012.28722